We agudicemos the imagination and producing teaching different models to those with which we learned we in public health.
Read More a Spanish study results finally dissipate doubts on what patients with spinal stenosis which worth operate.
qualified as “ the definitive study in this field ” for Spine, the main magazine scientific international.
-spinal stenosis is the most common cause of surgery back among those over 65 years
-The study defines what should be the sequence of treatment of patients with spinal stenosis symptom.
– identifies patients where surgery has proven to be the best option, and those in which there is no basis to raise it
– between the different surgical techniques availablethe most simple (and cheap) are more secure and perform better than the most complex
Madrid, November 2011- spinal stenosis is the narrowing of the bony canal which runs the marrow and often does not cause any problem. However, in some cases it is progressive and reaches compress nerve roots, which causes severe pain in the leg. It is the most common reason for surgery of back between the age 65 or over.
Various treatments, conservatives (pharmacological and rehabilitation) are used in these patients and surgical. But not a rigorous research on the comparative effectiveness of surgery and nonsurgical treatment for spinal stenosis, allowing to define criteria for the indication for each type of treatment was available until now.
A Spanish study has “ resolved definitively ” the doubts in this area. Thus specifies the main international scientific journal on spinal column, Spine, in his editorial. “We should congratulate the authors, since that is the definitive study in this field of research ” emphasizes the publication.
“The systematic review, driven by the Kovacs Foundation and co-financed by the Foundation itself with health research fund, used the most rigorous methods to identify all the studies conducted so far on this issue, analyze detail its characteristics and each scientific quality, and summarize their results in a few clear recommendations.
Its findings show that there is no basis to consider surgery in patients who do not have pain intense radiating leg (though they suffer from back pain and an MRI or CT show spinal stenosis), or those where irradiated pain lasts less than six months or improvement with conservative treatment.
“ Instead ”, indicates Dr. Francisco Kovacs, Director of the Spanish network of researchers on back problems and first author of the study, “ if radiated pain limits the quality of life of the patient and lasts more than 6 months despite conservative treatment is more effective to operate it which prolong treatment ”. “ the superiority of surgery manifests itself quickly and staysas a minimum, over 4 years, and probably 10 ” Apostille.
“ Notwithstanding ”, points out Dr. Gerard Urrútia, the epidemiology service of the Hospital de Sant Pau and the Iberoamerican Cochrane Centre, co-author of the study, “ delaying surgery not worsens the prognosis or exposes the patient to serious risks, therefore there is no urgency and is the patient who has to decide whether the limitations that cause pain justify the risks inherent in any surgery”.
Indications and risks of each treatment type
This study allows structured treatment as a whole on the basis of the indications and risks of each type of procedure. Thus, in patients in which an MRI or CT shows spinal stenosis:
-If there is no irradiated pain in the leg (although there is back pain), spinal stenosis should be considered only as a casual and irrelevant finding, that or it is a cause of problems or require treatment in itself same.
– in patients that spinal stenosis causes pain radiating to the leg, you must apply conservative treatment during the first 6 months.
-If this treatment despite the pain persists after that period and is sufficiently intense or limiting, is more effective to operate on the patient who maintain conservative therapy over more time.
– If the patient has more than 50 years, leg pain is only visible when walking and disappears when sitting down (“ claudication neur)(ógena ”), and there is no “ exceeding the I grade spondylolisthesis ” (i.e. the vertebrae are relatively well aligned), makes sense consider the placement of a “ interespinoso device ” between the vertebrae. It is a minimally invasive which leads to less blood loss than classical surgery and shortens stay hospital.
– If the patient does not meet these criteria, or the device has failed, be judged classical surgery. The surgery involves removing the portion of enough bone to decompress the nerve root (“ decompression surgery ”). Only in very specific cases (essentially, when the stenosis is due to a “ spondylolisthesis ” progressive) is justified, moreover, to fuse the vertebrae (“ fusion ”); in such cases techniques of simpler Arthrodesis (without apparatus, or with the least possible), are more secure and perform better than involving the introduction of more devices.
It would be advisable to immediately apply these criteria in the national health system, since currently tends to operate on patients where it is not necessary to do so, and to perform techniques unnecessarily complex, primarily for fixing the vertebrae, that expose patients to more risks, generate exorbitant costs and do worse.
In its response to the editorial commentary of the magazine, the authors point out that the study identifies patients where surgery is indicated, and point to “ taking into account growing surgery unnecessarily aggressive and expensive in most Western countries and the high rates ”, it is important to highlight that also “ helps identify patients for which there is no evidence that the surgery is useful ”.
“ In our institutions – concludes – the results of this review have dispelled doubts about the criteria to recommend surgery for patients with symptomatic spinal stenosis, and they have helped us provide more and better information about treatment alternatives and the expected results, in order to help them decide reasonably with respect to their own treatment ”.
Next steps
From the research point of view, the authors of this systematic review indicate that the next steps ought to be, first, to assess the effectiveness of each kind of conservative treatment which is used in these patients, both for applying them clinically (and discarding the useless), so that in future studies surgery can be compared to treatments targeted troops (and not)(, until now, a “ miscellaneous ” of conservative treatment which includes some of unknown or doubtful efficacy).
Also, indicate the need for studies comparing patients in which the placement of an interespinoso device is indicated its results, risks and costs in comparison to conventional surgery, in order to determine what technique is advisable in such cases, given that so far they have only compared separately both procedures versus conservative treatment.
Read Morenational experts address 34 Congress of the Iberian society of Biomechanics and biomaterials recent advances on the growth factors in the osteoarticular pathology
-The Congress, which has been organized by the Hospital San Juan de Dios and the University of Córdoba, held on 4 and 5 November at the Hotel Cordoba Center
– will address the newest techniques on Biomechanics Deportiva (high performance centres)
– will also cover aspects such as biomaterials, posturografÃa and balance, osteosynthesis in the foot, ozone therapy, and application of growth factors and cells mothers in the musculoskeletal system
Buenos Aires, November 2011- El San Juan de Dios Hospital Córdoba and the University of Cordoba have organized the XXXIV Congress of the Iberian society of Biomechanics and Biomaterials (SIIBB), which will take place at the Hotel Cordoba Center, being its opening tomorrow Friday, November 4, from 9: 00 hours.
This Congress has an exciting scientific program distributed in four panels, two workshops and several session of scientific communications.
The President of the Organizing Committee, Dr. Juan Lopez-Laserna, orthopedic surgeon of del Hospital San Juan de Dios in Córdoba, explained that “ the Congress aims to inform the latest advances on applications of medical ozone and the growth factors in the osteoarticular pathology, for participating physicians of the two major societies of ozone and Aepromo Seot ”.
Other bureaux will deal with other topics of interest such as the analysis of the balance and posture, Osteosynthesis foot Biomechanics and athletic performance and the inorganic Biomaterial interface biological tissue, for what will be specialists from throughout the national territory, the prestigious scientist who lived in Andalusia, who will speak about treatment in pathology with Dr. Raymond Hilu, articulate cells mothers.
The Congress is structured in three thematic areas such as: biomaterials, biomedicine and the sports biomechanics. This Congress, already consolidated by his years of preparation, is aimed at specialists in sports medicine, physical education, Traumatology and orthopedics, physiotherapy, nursing and engineering.
The complete program of the same may obtain it through the web http://juanlopezlaserna.es
Read MoreA high percentage of the prison population responds to treatment (Pegylated Interferon + Ribavirin) of hepatitis C.
Read More
La Fundación Pfizer Lorca handed their awards annual.
-Awards recognize the work of professionals and entities working for the advancement of knowledge and the improvement of the quality of life
-to Lorca carry this Act is the best way to show their emotional and personal support with the town after the earthquakes in the month of may
-this fact gives continuity to the solidarity action made Pfizer employees to collaborate in the most urgent needs
Lorca, November 2011- La Fundación Pfizer held last Friday, at the University of Lorca, his twelfth institutional Act of awards, citation of reference of this institution and the scenario in which acknowledges the work of excellent professionals, agencies and entities working for the advancement of knowledge, the promotion of health and the improvement of the quality of life in our country.
In its twelfth edition, the Pfizer Foundation, after chilling earthquakes that struck the town of Lorca in the month of may, decided to hold its annual Act of awards in this town, as a sign of solidarity. In this way, gives continuity to other actions in collaboration with Lorca by the biomedical company Pfizer throughout the year. thanks to the generosity of all employees, Pfizer made a donation to the city of Lorca a cheque worth 21.918 euros to cover the most urgent needs.
In this regard, the DRA. Elvira Sanz Urgoiti, President of the Foundation Pfizer says “ as well as economic, necessary support for the recovery of Lorca, we think that, above all, our moral and face-to-face support was necessary. For this reason, we decided to celebrate the most important of the Foundation here, annual event in Lorca. ”
chaired by the Mayor of Lorca, Francisco Jódar, and the Minister of health and Social policy, Murcia, MarÃa Angeles palaces, delivered the awards in the categories of biomedical research (both basic and clinical)Social commitment and communication (written press, radio and television).
The winners in different categories expressed a sincere thanks to the Pfizer Foundation by “ both appreciate his work, by having them distinguished and encourage them to continue their work in a very important area such as the improvement of health from points of view so different but complementary ”.
the celebration has been illustrious intervention of Dr. Santiago Moreno, also recognized murciano, Chief of service of infectious diseases at the Hospital Ramón y Cajal in Madrid and President of the Vihda Foundation. This Foundation works to increase hope and quality of life of people with HIV/AIDS in countries with low economic level and poor structure of social health and welfare organization.
Research Awards
The Pfizer Foundation Awards’s research support the relevant projects of Spanish scientists who contribute to lay the groundwork for advances in knowledge of diseases and thus enable the development of safe and effective medicines.
The work led by Dr. Carlos Belmonte, the Institute of Neurosciences of Alicante, and Dr. Miguel Martin of the Spanish (GEICAM) breast cancer research group have been awarded for this edition in the categories of basic research and clinical researchrespectively. Both awards are endowed with an amount of € 30,000.
The article entitled ‘ ocular surface moisture is regulated by dependent TRPM8 cold termorreceptores ’, published in Nature Medicine, and coordinated by Dr. Carlos Belmonte, shows the results of a study that opens up the possibility of that exposed mucous cold receptors (eye, mouth, vaginal …) contribute to the regulation of their degree of humidity. The data obtained in this work can help provide a way of regulating the humidification of these tissues, altered in pathologies such as dry eye, the epifora or excessive tear production, burning mouth or vaginal dryness.
For its part, the collective work of the GEICAM group, led by Dr. Miguel MartÃn has been published in the journal The New England Journal of Medicine. The study GEICAM 9805/Target has served to establish a new standard of treatment for breast cancer in early stages and has contributed data real women today are handled in the consultations. Also, as a step forward in the individualization of treatment of this, the most common tumor in women around the world.
Social commitment award
The program “ volunteering at shelters for families of children affected with hemophilia ” of the Spanish Federation of hemophilia has been the beneficiary entity in this category. This project is to equip all Spain families with children with hemophilia in an area of health education about the disease and treatment during 5 days 24 hours.
The Pfizer Foundation wanted to recognize this program that changes the view that parents have about hemophilia, conducive self-esteem and autonomy of children in the self-treatment of illness and supposed support for families.
Through this category, the Pfizer Foundation supports institutions that carry out projects to improve the quality of life of people. In this Edition, with a total allocation of 6,000 euros, have been particularly valued projects that promote social integration and to promote volunteerism targeted at the development of a future autonomous and independent of children and youth with disabilities.
The Board of Trustees of the Pfizer Foundation, in an exceptional way, wanted to make a special mention to the work of Regional Murcia of hemophilia Association for his work on the promotion of independent living and quality of children with this disorder between eight and 12 years.
Among the finalists were selected the following institutions: the Catalan Association for neuromuscular diseases, OncologÃa Infantil Enriqueta Villavecchia Foundation and the Malaga Association of AMARE rheumatoid arthritis.
communication award
media help spread the meaning of ‘ live with health ’, from the point of view of prevention and social and educational approach therefore Foundation awards each year to the professionals of the means of communication.
Carmen Giró have been recognized in this edition of ‘ La Vanguardia ’ (press written by story ‘ after myocardial ’), Luis Gutierrez and Bethlehem Almonacid de Onda Madrid (Radio, the programme dedicated to the ‘ world no tobacco day ’ ’) and Nuria Briongos) (TV)(, by reporting ‘ A match which starts at the incubator ’ and ‘ Glaucoma ’, broadcast on Antena 3), each of them with 6,000 euros.
Pfizer Foundation
Since 1999, the Foundation Pfizer has the Mission of improving health education of the Spanish population, through the promotion of the concept of healthy ageing, from any stage of life, as a natural, optimistic and dynamic process, to develop initiatives that recognize and support the researchinnovation, social commitment and the dissemination of knowledge on health.
Read More